Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nisbett

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 31, 1999
Aging, culture, and cognitionD C Park, R Nisbett, T Hedden
Future Oncology (London, England)|October 6, 2022
Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphomaAlnecia R Nisbett, Xiaoqin Yang, Patrick Squires, et al.
Clinical Lung Cancer|February 26, 2025
Patients With Advanced Non-small Cell Lung Cancer Harboring MET Alterations: A Descriptive Cohort StudyDina Oksen, Emmanuelle Boutmy, Yuexi Wang, et al.
Breast Cancer Research and Treatment|June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real worldMegan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 31, 1999
Aging, culture, and cognitionD C Park, R Nisbett, T Hedden
Future Oncology (London, England)|October 6, 2022
Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphomaAlnecia R Nisbett, Xiaoqin Yang, Patrick Squires, et al.
Clinical Lung Cancer|February 26, 2025
Patients With Advanced Non-small Cell Lung Cancer Harboring MET Alterations: A Descriptive Cohort StudyDina Oksen, Emmanuelle Boutmy, Yuexi Wang, et al.
Breast Cancer Research and Treatment|June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real worldMegan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Pageof 1